Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Pain Killing Protein Is Eight Times More Powerful than Morphine

By LabMedica International staff writers
Posted on 20 Oct 2008
Pain researchers have identified a protein produced by neurons that when injected into the spinal columns of experimental mice suppressed pain eight times more effectively than morphine did.

The protein under investigation, prostatic acid phosphatase (PAP) was shown by investigators at the University of North Carolina (Chapel Hill, USA) to be the same as a well-known neuron biomarker, fluoride-resistant acid phosphatase (FRAP). More...
This became apparent when mice genetically engineered to lack PAP activity were found to also lack FRAP.

The genetically engineered mice were more sensitive than normal mice to inflammatory pain and neuropathic pain, two common forms of chronic pain in humans. Furthermore, data published in the October 9, 2008, issue of the journal Neuron revealed that the increased pain sensitivities of the engineered mice diminished when they received injections of excess amounts of PAP into their spinal cords. The effectiveness of PAP injections was estimated to be about eight times that of morphine. Additionally, a single dose of PAP provided pain relief for up to three days, considerably longer than the five hours obtained from a dose of morphine.

"We were really blown away that a simple injection could have such a potent effect on pain,” said first author Dr. Mark J. Zylka, assistant professor of cell and molecular physiology at the University of North Carolina. "Not only that, but it appeared to work much better than the commonly used drug morphine. This protein has the potential to be a groundbreaking treatment for pain and has previously not been studied in pain-sensing neurons. It is entirely possible that PAP itself could be used as a treatment for pain, through an injection just like morphine, but we would like to modify it to be taken in pill form. By taking this field in a new direction, we are encouraged and hopeful that we will be able to devise new treatments for pain.”

Related Links:

University of North Carolina


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.